Ketorolac Tromethamine Injection, Solution
Product Images NDC 0409-3795

10 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 0409-3795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Ketorolac Tromethamine 01)

FDA Label Image

Structural Formula Of Ketorolac (Ketorolac Tromethamine 02)

Structural Formula Of Ketorolac (Ketorolac Tromethamine 02)
Chemical structure of Ketorolac Tromethamine showing molecular components with formula C15H13NO3 and C4H11NO3, depicting the combined chemical entities in this compound.*
FDA Label Image

Hospira Logo (Ketorolac Tromethamine 03)

FDA Label Image

Hospira Logo (Ketorolac Tromethamine 04)

FDA Label Image

Principal Display Panel (15 mg/mL Vial Label)

Principal Display Panel (15 mg/mL Vial Label)
Label for Ketorolac Tromethamine Injection, USP 15 mg/mL, single-dose 1 mL fill vial. The label indicates it is for intravenous and intramuscular use and is distributed by Hospira, Inc., Lake Forest, IL, USA. The label includes NDC 0409-3793-19 and has markings for batch and expiration date.*
FDA Label Image

Principal Display Panel (15 mg/mL Vial Tray)

Principal Display Panel (15 mg/mL Vial Tray)
Packaging label for Ketorolac Tromethamine Injection, USP 15 mg/mL in a 1 mL single-dose fliptop vial. This human prescription drug is for intravenous and intramuscular use and distributed by Hospira, Inc. The label includes NDC numbers 0409-3793-01 and 0409-3793-19, a barcode, and storage instructions.*
FDA Label Image

Principal Display Panel (30 mg/mL Vial Label)

Principal Display Panel (30 mg/mL Vial Label)
Ketorolac Tromethamine 30 mg/mL injection solution label for 1 mL single-dose fill. The label specifies use for intravenous and intramuscular administration. It includes the NDC number 0409-3795-19 and is distributed by Hospira, Inc., Lake Forest, IL, USA.*
FDA Label Image

Principal Display Panel (30 mg/mL Vial Tray)

Principal Display Panel (30 mg/mL Vial Tray)
Packaging label for Ketorolac Tromethamine Injection, USP 30 mg/mL single-dose fliptrop vial. The label states the drug is for intravenous and intramuscular use, distributed by Hospira, Inc., and includes barcodes and standardized product identifiers such as NDC numbers.*
FDA Label Image

Principal Display Panel (2 mL Vial Label)

Principal Display Panel (2 mL Vial Label)
Label for Ketorolac Tromethamine injection, USP, 60 mg/2 mL (30 mg/mL) single-dose vial. The label indicates the product is for intramuscular use only, distributed by Hospira, Inc., Lake Forest, IL. The label includes the NDC number 0409-3796-19 and a barcode.*
FDA Label Image

Principal Display Panel (2 mL Vial Tray)

Principal Display Panel (2 mL Vial Tray)
Label for Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL) by Hospira, Inc. The label indicates a single-dose 2 mL fill flipt-top vial for intramuscular use only. It includes NDC numbers 0409-3796-01 and 0409-3796-19 and states that 25 vials are contained per package. The label also provides a barcode and regulatory details such as lot and expiration dates (placeholders).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.